AKIGAI

Biotechnology Research • Oslo, Oslo, Norway • 1-10 Employees

Company overview

Headquarters	Oslo, Oslo, Norway
Website	akigai.no
NAICS	541714
Keywords	Biotech, Drug Development, Neuropathic Pain, Egfr Inhibitors
Founded	2023
Employees	1-10

Key Contacts at AKIGAI

Christian Kersten

Founder And Ceo

Marte Cameron

Founder And Cmo

AKIGAI Email Formats

AKIGAI uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@akigai.no), used 66.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@akigai.no	66.7%
{first initial}.{last name}	j.doe@akigai.no	33.3%

About AKIGAI

We have an obligation. Because we have witnessed the effects again and again. Like many breakthrough discoveries in medicine, the understanding that relief of neuropathic pain was a result of EGFR inhibition came serendipitously.

AKIGAI revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,000,000
Total funding	No funding